shipment_ID,catalog_ID,Formula,stereochemistry,sample_MW,purity,PO,Salt_Name,Salt_ratio,MW_salt,volume(uL),concentration(mM),plate_ID,well,SMILES,Name,Batch ID
ALP-UNI-4b8a177c-1,Z4760610405,C19H15ClN2O3,Racemic or presumed racemic or meso,354.787,90,200415-FTE / COVID-19,,,0,40,20,1181202-Y40-27,03_A,OC=1C=CC(Cl)=C2C(CCOC12)C(=O)NC=3C=NC=C4C=CC=CC34,"5-chloro-8-hydroxy-N-(isoquinolin-4-yl)-3,4-dihydro-2H-1-benzopyran-4-carboxamide",H2728816
ALP-POS-568d9d36-1,Z4763564701,C21H16ClIN4O2,Racemic or presumed racemic or meso,518.734,100,200415-FTE / COVID-19,,,0,40,20,1181202-Y40-27,03_B,ClC=1C=CC(NC(=O)C(N(C(=O)C=C)C=2C=CC(I)=CC2)C=3C=NC=NC3)=CC1,N-{[(4-chlorophenyl)carbamoyl](pyrimidin-5-yl)methyl}-N-(4-iodophenyl)prop-2-enamide,T4065174
ALP-POS-a3de0cb1-6,Z4618924259,C22H20N4O,Racemic or presumed racemic or meso,356.420,100,200415-FTE / COVID-19,,,0,40,20,1181202-Y40-27,03_C,CC=1C=CC(=CC1)C(CC=2C=CC=CC2)C(=O)NC=3N=NN4C=CC=CC34,"2-(4-methylphenyl)-3-phenyl-N-{[1,2,3]triazolo[1,5-a]pyridin-3-yl}propanamide",H2733921
MAT-POS-044491d2-3,Z4609618441,C18H17ClF3N3O,Diastereomeric mixture,383.795,100,200415-FTE / COVID-19,,,0,40,20,1181202-Y40-27,03_D,CC=1C=CN=CC1NC(=O)CC=2C=C(Cl)C=C(NC3CC3C(F)(F)F)C2,2-(3-chloro-5-{[2-(trifluoromethyl)cyclopropyl]amino}phenyl)-N-(4-methylpyridin-3-yl)acetamide,H2736983
MAT-POS-044491d2-6,Z4609618444,C21H24ClF2N3O,Achiral,407.884,100,200415-FTE / COVID-19,,,0,40,20,1181202-Y40-27,03_E,CC=1C=CN=CC1NC(=O)CC=2C=C(Cl)C=C(NC3(C)CCC(F)(F)CC3)C2,"2-{3-chloro-5-[(4,4-difluoro-1-methylcyclohexyl)amino]phenyl}-N-(4-methylpyridin-3-yl)acetamide",H2726088
PET-UNK-372a2f82-1,Z4721204105,C21H18Cl2N4O,Achiral,413.299,96.9,200415-FTE / COVID-19,hydrogen chloride,1,36.46094,40,20,1181202-Y40-27,03_F,Cl.ClC=1C=C(CC(=O)NC=2C=NC=C3C=CC=CC23)C=C(CC4=CC=NN4)C1,2-{3-chloro-5-[(1H-pyrazol-5-yl)methyl]phenyl}-N-(isoquinolin-4-yl)acetamide hydrochloride,H2726106
